NATUREBANK TO POSTONE FILING OF FINANCIAL STATEMENTS AND MD&A’s DUE TO COVID-19 RELATED DELAYS

NatureBank Asset Management Inc.

News Release

April 21, 2020

NATUREBANK TO POSTONE FILING OF FINANCIAL STATEMENTS AND MD&A’s DUE TO COVID-19 RELATED DELAYS

April 21, 2020, Vancouver, British Columbia: NatureBank Asset Management Inc. (the “Company”) (TSX-V: COO, Frankfurt: 9EA) wishes to announce that it will delay filing both its annual financial statements and management's discussion and analysis for the year ending December 31, 2019 (the "Annual Documents") and its first quarter interim financial statements and management's discussion and analysis for the first quarter interim period ending March 31, 2020 (the "Interim Documents").

NatureBank has altered its office operations over the last four weeks and has followed the directions of the BC Provincial Health Office (“Health Office”) in response to the Covid-19 pandemic.

In announcing this delay, the Company is relying on exemptive relief that has been granted by Canadian securities regulatory authorities, including the British Columbia Securities Commission (“BCSC”), that allows it to delay the filing of the Annual Documents, which would otherwise be due under National Instrument 51-102 on April 29, 2020, and the Interim Documents, which would otherwise be due under National Instrument 51-102 on June 1, 2020. A copy of the temporary exemption granted by the BCSC in response to the Covid-19 Pandemic, can be found here: BC Instrument 51-515.

The Company’s Annual Documents and its Interim Documents are expected to be filed, in the case of the Annual Documents, on or before June 15, 2020 and, in the case of the Interim Documents, on or before July 16, 2020. As required under Section 10 (2) and (3) of BC Instrument 51-515, the Company will also file required updates related to its progress with these filings. Until such time as the Annual Documents and the Interim Documents are filed, the Company's management and other insiders are subject to a trading blackout that reflects the principles contained in Section 9 of National Policy 11-207 - Failure-To-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

There have been no material business developments since the date of the last interim financial statements and management's discussion and analysis for the nine months ended September 30, 2019 which were filed on SEDAR on November 29, 2019. The Company has made other filings on SEDAR which are available at www.sedar.com.

Phil Cull
CEO
NatureBank Asset Management Inc.

About NatureBank

NatureBank specializes in advisory, technology and project investment services applied to sustainable commodities and ecological assets, with a primary focus on carbon. We provide our customers with a multidisciplinary approach to managing risk, enhancing asset performance and securing commercial returns. While managing climate change risk, we improve livelihoods and sustainability in project regions. Through our advisory services team and our subsidiary company, Offsetters, we help organizations understand, reduce and offset their climate impact. With offices in Vancouver, British Columbia; and Portland, Oregon; our team has a global reach. We have worked with over 200 leading business organizations including Aimia, Vancity, lululemon athletica, Catalyst Paper, Harbour Air, HSE - Entega, and Shell Canada Limited. NatureBank is publicly listed company on the Toronto Venture Exchange (TSX-V:COO) and in Frankfurt:9EA. Please visit us at www.NatureBank.com.

Forward Looking Statements

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the anticipated terms of proposed transaction. Information and statements which are not purely historical fact are forward-looking statements. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including the risks that required approvals will not be obtained or that other conditions to completion of the transaction will not be satisfied or waived and that the transaction will not close on the terms as anticipated by management of the Company or at all. The assumptions on which the forward looking statements contained herein rely include that required approvals will be obtained and the other conditions to completion of the transaction will be satisfied and the transaction will close on the expected terms. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

David Rokoss
NatureBank Asset Management Inc.
Suite 300 – 948 Homer Street,
Vancouver BC, V6B 2W7
Telephone: 604-760-1997

Email: david.rokoss@NatureBank.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.